23 related articles for article (PubMed ID: 38757924)
1. COVID-19 was associated with the complications after allogeneic hematopoietic stem cell transplantation.
Wen Q; Guo Z; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Sun YQ; Huang XJ; Mo XD
Sci Rep; 2024 May; 14(1):11778. PubMed ID: 38782966
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies.
Wu TY; Tsai WT; Chen KH; Huang ST; Huang CF; Kuo PH; Tsai MJ; Liu WD; Lin KY; Huang YS; Cheng A; Chen PY; Sun HY; Huang HH; Huang TC; Wu SJ; Yao M; Wang JT; Sheng WH; Hung CC; Chen YC; Chang SC
J Microbiol Immunol Infect; 2024 Jun; 57(3):403-413. PubMed ID: 38480093
[TBL] [Abstract][Full Text] [Related]
3. Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection.
Lee BJ; Vittayawacharin P; Griffin SP; Doh J; Nam HH; Jeyakumar D; Blodget E; Kongtim P; Ciurea SO
Transplant Cell Ther; 2024 May; ():. PubMed ID: 38710303
[TBL] [Abstract][Full Text] [Related]
4. Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities.
Velasco Puyó P; Tagarro A; Garcia-Obregon S; Villate O; Moraleda C; Huerta Aragonés J; Bardón Cancho EJ; Faura Morros A; Galán-Gómez V; Escobar Fernández L; Lendinez-Molinos F; Herrero Velasco B; Ureña Horno L; Domínguez-Pinilla N; Pascual Gazquez JF; Nova Lozano C; Osuna-Marco M; Marín-Cruz I; Gomez Pastrana I; Garcia de Andoin Barandiaran N; Gallego Mingo N; Portugal Rodríguez R; Cañete A; Pareja León M; Castrillo Bustamante S; Tallón García M; Gónzalez-Prieto A; Solé-Rodríguez M; González Cruz M; Soriano-Arandes A; Mota M; Pérez-Hoyos S; Moreno L; Astigarraga I;
Pediatr Blood Cancer; 2024 Aug; 71(8):e31120. PubMed ID: 38825724
[TBL] [Abstract][Full Text] [Related]
5. The impact of prior COVID-19 on non-infectious endothelial complications following allogeneic hematopoietic stem cell transplantation.
Oltolini C; Travi G; Mikulska M
Clin Infect Dis; 2024 Jun; ():. PubMed ID: 38835096
[No Abstract] [Full Text] [Related]
6. Clinical Manifestations of Pulmonary Mucormycosis in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A 21-Case Series Report and Literature Review.
Bao J; Liu C; Dong Y; Xu Y; Wang Z; Sun K; Xi W; Wang K; Gong P; Gao Z
Can Respir J; 2022; 2022():1237125. PubMed ID: 35692949
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
Shahzad M; Chaudhary SG; Zafar MU; Hassan MA; Hussain A; Ali F; Anwar I; Ahmed M; Ahmed N; Khurana S; Rauf MA; Anwar F; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transpl Infect Dis; 2022 Apr; 24(2):e13792. PubMed ID: 35030267
[TBL] [Abstract][Full Text] [Related]
8. Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study.
Barkhordar M; Chahardouli B; Biglari A; Ahmadvand M; Bahri T; Alaeddini F; Sharifi Aliabadi L; Noorani SS; Bagheri Amiri F; Biglari M; Shemshadi MR; Ghavamzadeh A; Vaezi M
Front Immunol; 2023; 14():1169666. PubMed ID: 37153556
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia.
Oltolini C; Acerbis A; Orofino G; Racca S; Noviello M; Dispinseri S; Clementi N; Piemontese S; Xue E; Giglio F; Lupo Stanghellini MT; Diral E; Bruno A; Tassi E; Beretta V; Marzinotto I; Scarlatti G; Lampasona V; Ardemagni A; Sampaolo M; Bonini C; Corti C; Peccatori J; Castagna A; Ciceri F; Greco R
Front Immunol; 2023; 14():1184956. PubMed ID: 37287986
[TBL] [Abstract][Full Text] [Related]
10. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P
Front Immunol; 2021; 12():605766. PubMed ID: 34025637
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
[TBL] [Abstract][Full Text] [Related]
12. Impact of prior COVID-19 infection on allogeneic hematopoietic stem cell transplantation outcomes.
Siniaev A; Popova M; Rogacheva Y; Ianbukhtina V; Kulagin E; Vladovskaya M; Bondarenko S; Moiseev I; Kulagin AD
Clin Transplant; 2024 May; 38(5):e15331. PubMed ID: 38757924
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
